AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 297: G434-G441, 2009. First published July 16, 2009; doi:10.1152/ajpgi.00152.2009
0193-1857/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/3/G434    most recent
00152.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Blaine, S. A.
Right arrow Articles by Means, A. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blaine, S. A.
Right arrow Articles by Means, A. L.

HORMONES AND SIGNALING

Epidermal growth factor receptor regulates pancreatic fibrosis

Stacy A. Blaine,1 Kevin C. Ray,1 Kevin M. Branch,1 Pamela S. Robinson,2 Robert H. Whitehead,2 and Anna L. Means1,3

Departments of 1Surgery, 2Medicine, and 3Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee

Submitted 24 April 2009 ; accepted in final form 12 July 2009

The development of pancreatic fibrosis has been shown to be a major component in several diseases of the pancreas including pancreatic cancer, chronic pancreatitis, and type 2 diabetes mellitus, but its actual role in the progression of these disorders is still unknown. This fibrosis is characterized by stromal expansion and the excessive deposition of extracellular matrix (ECM) that replaces pancreatic tissue. This eventually leads to dysregulation of ECM turnover, production of cytokines, restriction of blood flow, and often exocrine and endocrine insufficiencies. Activated pancreatic stellate cells (PSCs) have been identified as key mediators in the progression of pancreatic fibrosis, serving as the predominant source of excess ECM proteins. Previously, we found that overexpression of the growth factor heparin-binding epidermal growth factor-like growth factor (HB-EGF) in pancreatic islets led to intraislet fibrosis. HB-EGF binds to and activates two receptors, epidermal growth factor receptor (EGFR) and ErbB4, as well as heparin moieties and CD9/DRAP27. To understand the mechanism underlying the induction of fibrogenesis by HB-EGF, we utilized a hypomorphic allele of Egfr, the Waved-2 allele, to demonstrate that EGFR signaling regulates fibrogenesis in vivo. Using an in vitro cell migration assay, we show that HB-EGF regulates both chemoattraction and stimulation of proliferation of PSCs via EGFR activation.

heparin-binding epidermal growth factor-like growth factor; pancreatic stellate cells; Waved-2



Address for reprint requests and other correspondence: A. Means, Dept. of Surgery, Vanderbilt Univ. Medical Center, 10445 MRB IV, 2213 Garland Ave., Nashville, TN 37232-0443 (e-mail: anna.means{at}vanderbilt.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.